Quality of life (QOL) improvements for pomalidomide plus low-dose dexamethasone (POM plus LoDEX) in relapsed and refractory multiple myeloma (RRMM) patients (pts) enrolled in MM-003

被引：0

作者：

Song, Kevin W.

Dimopoulos, Meletios A.

Weisel, Katja C.

Moreau, Philippe

Lacy, Martha

Delforge, Michel

Karlin, Lionel

Goldschmidt, Hartmut

Banos, Anne

Rocafiguera, Albert Oriol

Hudgens, Stacie

Yu, Zhinuan

Sternas, Lars

Jacques, Christian

Zaki, Mohamed H.

San-Miguel, Jesus F.

机构：

[1] Vancouver Gen Hosp, Vancouver, BC, Canada

[2] Alexandra Hosp, Athens, Greece

[3] Univ Tubingen Hosp, Dept Med, Tubingen, Germany

[4] Univ Hosp Hotel Dieu, Nantes, France

[5] Mayo Clin, Rochester, MN USA

[6] Katholieke Univ Leuven Hosp, Dept Hematol, Louvain, Belgium

[7] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France

[8] Univ Klinikum Heidelberg, Heidelberg, Germany

[9] Ctr Hosp Cote Basque, Bayonne, France

[10] HGTiP, Inst Catala Oncol, Barcelona, Spain

[11] Adelphi Values, Boston, MA USA

[12] Celgene Corp, Summit, NJ USA

[13] Hosp Univ Salamanca, Salamanca, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8583

引用

页数：1